Showing 2721-2730 of 3039 results for "".
- Trump Administration Pushes for Health Care Facilities to Reopenhttps://modernod.com/news/trump-administration-pushes-for-health-care-facilities-to-reopen/2477892/Healthcare facilities in states that have seen enough of a decline in COVID-19 cases to reach the Phase II criteria for reopening their economies should begin offering nonemergent, non-COVID-19 care, the Trump administration said Monday, according to a FierceHealthcare
- Vasoptic Medical Receives FDA 510(k) Clearance for Retinal Imaging Devicehttps://modernod.com/news/vasoptic-medical-receives-fda-510k-clearance-for-retinal-imaging-device/2477882/Vasoptic Medical has received 510(k) clearance from the FDA for its XyCAM RI noninvasive retinal imager. The XyCAM RI provides dynamic and quantifiable blood flow measurement synchronized with finger pulse oximeter data. The device
- Oxford Biomedica Snags Manufacturing Equipment to Ramp Up Production of COVID-19 Vaccinehttps://modernod.com/news/oxford-biomedica-snags-manufacturing-equipment-to-ramp-up-production-of-covid-19-vaccine/2477880/In the race for a COVID-19 vaccine, the University of Oxford has stormed to an early lead with the commercial manufacturing support of British drugmaker AstraZeneca. Now, in an effort to scale up capacity for global demand, one of AstraZeneca’s manufacturing partners has struck a deal for n
- Implandata Launches Eyemate IOP-Tracking Service for Remote Monitoring and Improved Glaucoma Carehttps://modernod.com/news/implandata-launches-eyemate-iop-tracking-service-for-remote-monitoring-and-improved-glaucoma-care/2477870/Implandata Ophthalmic Products announced the launch of its web-based Eyemate IOP-Tracking Service for remote monitoring and management of glaucoma. The Eyemate provides eye doctors with IOP measurements collected anytime under patients’ normal life conditions. “Remote IOP monitoring provid
- HHS Requiring Labs to Report Patients’ Race, Ethnicity With COVID-19 Tests in Effort to Combat Disparitieshttps://modernod.com/news/hhs-requiring-labs-to-report-patients-race-ethnicity-with-covid-19-tests-in-effort-to-combat-disparities/2477867/Following outcries from lawmakers and the public about the lack of demographic data for COVID-19 testing, the Trump administration is now requiring laboratories to collect demographic data like race, ethnicity, and sex when reporting test results, according to a FierceHealthcare
- SightGlass Vision Granted CE Mark for Eyeglasses That Slow Myopia Progression in Childrenhttps://modernod.com/news/sightglass-vision-granted-ce-mark-for-novel-eyeglasses-that-slow-myopia-progression-in-children/2477859/SightGlass Vision announced it has achieved CE Mark approval for its first product – novel eyeglasses designed to slow the progression of myopia in children. The approval allows the SightGlass Vision to commercialize its suite of Diffusion Optics Technology (DOT) products across the EU,
- Lilly Begins World’s First Human Study of Antibody to Treat COVID-19https://modernod.com/news/lilly-begins-worlds-first-human-study-of-antibody-to-treat-covid-19/2477853/Eli Lilly said that the first patients have been dosed in a phase 1 trial investigating the experimental antibody LY-CoV555 for the treatment of COVID-19. The company, which is developing the drug with partner AbCellera, noted that the move marks the world’s first study of a potential antib
- Nicox Initiates First Phase 3 Trial of NCX 470 in Glaucomahttps://modernod.com/news/nicox-initiates-first-phase-3-trial-of-ncx-470-in-glaucoma/2477855/Nicox announced the initiation of the first phase 3 clinical trial, Mont Blanc, evaluating NCX 470 for the lowering of IOP in patients with open-angle glaucoma or ocular hypertension, by enrolling the first 12 patients. NCX 470 is the company’s novel, second-generation nitric oxide (NO)-donating
- Can You Catch COVID-19 Through Your Eyes?https://modernod.com/news/can-you-catch-covid-19-through-your-eyes/2477840/You can catch COVID-19 if an infected person coughs or sneezes and contagious droplets enter your nose or mouth. But can you become ill if the virus lands in your eyes? Virologist Joseph Fair, PhD, an NBC News contributor, raised that concern when he became critically ill with COVID-19, ac
- New Alcon Program Aims to Help ECPs Tap Into Opportunities in the Dry Eye Market Amid COVID-19 Crisishttps://modernod.com/news/new-alcon-program-aims-to-help-ecps-tap-into-opportunities-in-the-dry-eye-market-amid-covid-19-crisis/2477838/Alcon has launched a new program called “No Reason to Wait: Success Starts Now” aimed at helping eye care professionals (ECPs) better understand the practice and patient benefits of treating the root cause of evaporat